EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | +62.5% | 26,782 | +459.9% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 4,783 | +168.4% | 0.00% | – |
| Q2 2022 | $55,000 | -24.7% | 1,782 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | +15.9% | 1,782 | +41.3% | 0.00% | – |
| Q3 2021 | $63,000 | -32.3% | 1,261 | -15.5% | 0.00% | – |
| Q2 2021 | $93,000 | -99.7% | 1,492 | -99.6% | 0.00% | -100.0% |
| Q1 2021 | $34,482,000 | +10.2% | 371,138 | +6.2% | 0.04% | +5.0% |
| Q4 2020 | $31,299,000 | -9.3% | 349,324 | +4.6% | 0.04% | -18.4% |
| Q3 2020 | $34,524,000 | +32.8% | 334,118 | +1.6% | 0.05% | +22.5% |
| Q2 2020 | $26,004,000 | +19.9% | 328,835 | -12.3% | 0.04% | 0.0% |
| Q1 2020 | $21,684,000 | -25.4% | 374,770 | -30.5% | 0.04% | -4.8% |
| Q4 2019 | $29,082,000 | -6.7% | 539,055 | -9.6% | 0.04% | -17.6% |
| Q3 2019 | $31,169,000 | -10.3% | 596,195 | -17.2% | 0.05% | -8.9% |
| Q2 2019 | $34,765,000 | – | 719,630 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |